Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
45 participants
INTERVENTIONAL
2011-11-30
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low intensity resistance training
Exercise training
12 weeks of resistance training twice a week.
High intensity resistance training
Exercise training
12 weeks of resistance training twice a week.
Low intensity resistance training with vascular occlusion
Resistance training with vascular occlusion
12 weeks of resistance training with vascular occlusion twice a week
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise training
12 weeks of resistance training twice a week.
Resistance training with vascular occlusion
12 weeks of resistance training with vascular occlusion twice a week
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI \<39
* Knee Ostearthritis type II and III
* VAS (visual analogue scale) between 2 and 8
Exclusion Criteria
* Use of NSAID
50 Years
65 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sao Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bruno Gualano
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Sao Paulo -School of Medicine - Clinical Hospital
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Rodrigo Ferraz, Msc
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
vascular occlusion and OA
Identifier Type: -
Identifier Source: org_study_id